Clinical Trial Update: Hyperpolarized 13C-MRI in Patients With Hepatocellular Carcinoma Undergoing Radiotherapy, Atezolizumab, and Bevacizumab [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial at Chang Gung Memorial Hospital is evaluating hyperpolarized 13C-MRI as a biomarker in hepatocellular carcinoma patients undergoing rad…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Atezolizumab (atezolizumab)
• Bevacizumab (bevacizumab)

Snippet

Sponsor: Chang Gung Memorial Hospital | Conditions: Hepatocellular Carcinoma (HCC) | Phase 2 | Status: RECRUITING